Evaxion Biotech A/S - American Depositary Share Depository Receipt · US29970R2040 · EVAX (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Evaxion Biotech A/S - American Depositary Share

No Price

13.05.2026 18:39

Current Prices from Evaxion Biotech A/S - American Depositary Share

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	EVAX	USD	13.05.2026 18:39	4,30 USD	0,13 USD +3,12 %
IEX	EVAX	USD	13.05.2026 16:50	4,31 USD	0,13 USD +3,24 %

Company Profile for Evaxion Biotech A/S - American Depositary Share Depository Receipt

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.